Community Based Doulas for Migrant Women in Labour and Birth in Sweden - a Randomised Controlled Trial
Labor Pain, Satisfaction, Consumer, Language
About this trial
This is an interventional health services research trial for Labor Pain
Eligibility Criteria
Inclusion Criteria:
- Nulliparous and multiparous pregnant women
- 25-36 weeks gestation
- Somali-, Arabic-, Russian- or Tigrinya-speaking
- Cannot communicate fluently in Swedish
- No contra-indications for vaginal birth
Exclusion Criteria:
- Planned caesarean birth
- Not consenting to access to their birth records
- 17 years old or younger
Sites / Locations
- Erica Schytt
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Community-based doula support for labour
Standard labour support
Women will receive support from a Community-based doula (CBD) plus standard labour support. Women will meet twice with the CBD prior to the birth to get to know each other and discuss the woman's wishes regarding support in labour and what the CBD can offer. The CBD will then stay with her throughout her labour and birth and support her with interpretation/Communication with the staff and emotional and instrumental support. The CBD-support will be in addition to any other support people she may have, such as her partner. Note: Women partner and/or other support people to accompany throughout her childbirth will be allowed, regardless of their trial allocation. CBDs will be recruited, trained and employed by non-profit organization MIRA, using well-tested processes.
Standard labour support by health care providers only. Women allocated to the comparison arm of the trial will receive standard intrapartum care as provided at their chosen hospital of birth. That is emotional, information and instrumental support from a helping nurse or a midwife or in some cases a doctor. The support includes caring actions, such as comforting, massage, information and presence. Note: Women partner and/or other support people to accompany throughout her childbirth will be allowed, regardless of their trial allocation.